Medical devices, healthcare technology and the business of care
510(k) clearance · K260271

Strauss Surgical cystoscope, hysteroscope and accessories Instruments

American Medical Endoscopy, Inc. · Decision date Mar 27, 2026

FDA DECISIONK260271

What did the FDA decide?

FDA records K260271 as a 510(k) premarket notification, with a decision dated Mar 27, 2026. The decision code SESE records a finding of substantial equivalence. This is a 510(k) clearance.

Regulatory pathway
510(k) premarket notification
Clinical specialty
Gastroenterology, Urology
Decision date
Mar 27, 2026

FDA source record

Regulatory record facts

Identifier
K260271
Regulatory pathway
510(k) premarket notification
Product code
FAJ
Decision code
SESE
Decision date
Mar 27, 2026
Source update
Nov 9, 2026
Original record
Open FDA source record

About this medical device

FDA device category: Cystoscope And Accessories, Flexible/Rigid.

Product code
FAJ
FDA device class
2

FDA decision timeline

  1. K260271 received

    Application receipt date recorded by FDA.

  2. K260271 · FDA decision

    SESE

Related devices and submissions

Explore the linked device profile

Other records with product code FAJ

Product / regulatory recordCompanyPathwayDecision dateSource
Strauss Surgical USA510(k) clearanceOct 30, 2026FDA
OLYMPUS WINTER & IBE GMBH510(k) clearanceMay 21, 2026FDA
Verathon Medical (Canada) Ulc510(k) clearanceMay 11, 2026FDA
Strauss Surgical USA510(k) clearanceApr 16, 2026FDA
Cogentix Medical, Inc.510(k) clearanceApr 7, 2026FDA

A shared product code identifies a classification relationship; it does not establish clinical equivalence.

Regulatory context

A 510(k) submission seeks a finding of substantial equivalence to a legally marketed device. A clearance and a PMA approval are different regulatory decisions.

Read our guide to FDA clearance and approval · FDA’s explanation of this pathway

Manufacturer intelligence

American Medical Endoscopy, Inc.

Headquarters
Not reported
Brand website
Not reported
FDA applicant address
Doral, FL

Sources and methodology

FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.

How we use FDA records